UCLA researchers have developed a new kind of immunotherapy that harnesses the body’s immune system to fight cancer more effectively. The innovative cell therapy uses specially engineered immune cells ...

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient's immune cells to fight cancer.

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of supercharged T cells that are stronger, ...

These cancer patients had a common gene mutation called PIK3CA. There was a 7.7 percent recurrence rate in the aspirin takers compared to a 14 percent return in the people on placebo. That is a ...

University researchers have pioneered a new tool to determine the risk of secondary heart attacks in cancer patients using Artificial Intelligence. Cancer patients who suffer a heart attack face ...